BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerber GF, Yuan X, Yu J, Cher BAY, Braunstein EM, Chaturvedi S, Brodsky RA. COVID-19 vaccines induce severe hemolysis in paroxysmal nocturnal hemoglobinuria. Blood 2021;137:3670-3. [PMID: 33945618 DOI: 10.1182/blood.2021011548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fattizzo B, Giannotta JA, Cecchi N, Barcellini W. SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor. Am J Hematol 2021;96:E344-6. [PMID: 34057236 DOI: 10.1002/ajh.26262] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
2 Hidaka D, Ogasawara R, Sugimura S, Fujii F, Kojima K, Nagai J, Ebata K, Okada K, Kobayashi N, Ogasawara M, Imamura M, Ota S. New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination. Int J Hematol 2021. [PMID: 34687421 DOI: 10.1007/s12185-021-03243-2] [Reference Citation Analysis]
3 Fattizzo B, Pasquale R, Bellani V, Barcellini W, Kulasekararaj AG. Complement Mediated Hemolytic Anemias in the COVID-19 Era: Case Series and Review of the Literature. Front Immunol 2021;12:791429. [PMID: 34899761 DOI: 10.3389/fimmu.2021.791429] [Reference Citation Analysis]
4 Wu V, Lopez CA, Hines AM, Barrientos JC. Haemophagocytic lymphohistiocytosis following COVID-19 mRNA vaccination. BMJ Case Rep 2022;15:e247022. [PMID: 35296502 DOI: 10.1136/bcr-2021-247022] [Reference Citation Analysis]
5 Magro C, Crowson AN, Franks L, Schaffer PR, Whelan P, Nuovo G. The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin. Clinics in Dermatology 2021;39:966-84. [DOI: 10.1016/j.clindermatol.2021.07.011] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Portuguese AJ, Sunga C, Kruse-Jarres R, Gernsheimer T, Abkowitz J. Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv 2021;5:2794-8. [PMID: 34255033 DOI: 10.1182/bloodadvances.2021004957] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Giannotta JA, Fattizzo B, Bortolotti M, Girmenia C, Ielo C, Metafuni E, Visentin A, Apolito V, Lucchesi A, Giai V, Beggiato E, Di Bona E, Giglio F, Sica S, Iori AP, Barcellini W. SARS-CoV-2 vaccination in patients with paroxysmal nocturnal hemoglobinuria: An Italian multicenter survey. Am J Hematol 2022;97:E229-32. [PMID: 35319125 DOI: 10.1002/ajh.26545] [Reference Citation Analysis]
8 Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Reference Citation Analysis]
9 Dolai TK, Sen A. Vaccination for the novel coronavirus disease in hematological disorders. JHAS 2021;1:59-68. [DOI: 10.25259/jhas_18_2021] [Reference Citation Analysis]
10 Jarrah K, Al Mahmasani L, Atoui A, Bou-Fakhredin R, Taher AT. Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination. Blood Cells Mol Dis 2022;93:102641. [PMID: 34980554 DOI: 10.1016/j.bcmd.2021.102641] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kulasekararaj AG, Brodsky RA, Nishimura JI, Patriquin CJ, Schrezenmeier H. The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria. Ther Adv Hematol 2022;13:20406207221091046. [PMID: 35663504 DOI: 10.1177/20406207221091046] [Reference Citation Analysis]
12 Vorster L, Kirk SE, Muscal E, Despotovic JM, Cohen CT, Sartain SE. COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents. Pediatr Blood Cancer 2022;69:e29681. [PMID: 35373880 DOI: 10.1002/pbc.29681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sherwani S, Rajendrasozhan S, Khan MWA, Saleem M, Khan M, Khan S, Raafat M, Othman Alqahtani F. Pharmacological Profile of Nigella sativa Seeds in Combating COVID-19 through In-Vitro and Molecular Docking Studies. Processes 2022;10:1346. [DOI: 10.3390/pr10071346] [Reference Citation Analysis]